regdanvimab: Clinical Trials

1 trial of regdanvimab, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Unknown 1

Follow regdanvimab: new trials by email Literature Review of regdanvimab trials Research Report on regdanvimab

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of Tixagevimab/Cilgavimab and Regdanvimab Efficacy for Treatment of COVID-19
tixagevimab/cilgavimab 150+150 mg, tixagevimab/cilgavimab 300+300 mg, regdanvimab - Coronavirus Infections
Phase 4UnknownCity Clinical Hospital No.52 of Moscow Healthcare Department822022-08-182023-08-08

Conditions studied

Coronavirus Infections (1)

Sponsors

City Clinical Hospital No.52 of Moscow Healthcare Department (1)

Countries

Russia (1)

Results publications

PMID 37928549